Use the federal government's buying power to negotiate lower prescription drug prices for Medicare patients.

She believes the federal government should use its considerable buying power to negotiate for Medicare patients.

Calls for Medicare drug-price negotiation using federal purchasing power.

Issues - Chellie Pingree for Congress : Chellie Pingree for Congress
campaign · campaign_site · model gpt-5.4-mini

Pingree said she was "working to change the way Medicare buys prescription drugs" and called it "crazy" that Medicare was not allowed to negotiate a better deal. The release says she co-sponsored H.R. 684, which would require the Secretary of Health and Human Services to negotiate the purchase price of covered Part D drugs with pharmaceutical manufacturers.

Shows Pingree explicitly backing the core promise of using federal bargaining power to lower Medicare drug prices.

partial same_term A for effort

Pingree, Van Hollen introduce discount prescription drug plan | U.S. Representative Chellie Pingree
secondary · model gpt-5.4-mini · confidence 93%

Roll Call 420 records the House vote on H.R. 5376, the Inflation Reduction Act of 2022, which passed 220-207 on the motion to concur in the Senate amendment. Pingree was a member of the House at the time and voted in favor of the measure.

Pingree backed the enacted bill that created Medicare drug-price negotiation authority.

delivered same_term A for effort

Office of the Clerk, U.S. House of Representatives - Roll Call 420
secondary · model gpt-5.4-mini · confidence 86%

Pingree wrote that she had been pursuing Medicare drug price negotiation for decades and said the Inflation Reduction Act's provision allowing Medicare to negotiate drug prices was monumental. The page describes the law as the first time Medicare is empowered to negotiate prescription drug prices and says it will lower drug costs.

Confirms Pingree publicly claimed the enacted law achieved the policy she had long sought.

delivered same_term

The Inflation Reduction Act | U.S. Representative Chellie Pingree
secondary · model gpt-5.4-mini · confidence 95%

CMS said that, for the first time in history, Medicare will have the ability to negotiate lower prescription drug prices because of the Inflation Reduction Act. The guidance launched implementation of the Medicare Drug Price Negotiation Program for 2026.

Official federal implementation confirms the promise was turned into operative policy, not just enacted on paper.

delivered same_term

HHS Releases Initial Guidance for Historic Medicare Drug Price Negotiation Program for Price Applicability Year 2026 | CMS
secondary · model gpt-5.4-mini · confidence 92%

CMS announced the first negotiated prices under the Medicare Drug Price Negotiation Program and said projected savings for people with Medicare Part D coverage would be about $1.5 billion when the prices take effect in 2026.

Shows the government actually negotiated lower Medicare drug prices and identified concrete savings.

delivered same_term

Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026 | CMS
secondary · model gpt-5.4-mini · confidence 97%